 445-453 (1997) 
Introduction
Clinical observations in North America (1-7) and Europe (8) point to an expanding group of patients who report sensitivities to extraordinarily low levels of environmental chemicals. This phenomenon, termed chemical sensitivity or multiple chemical sensitivity, appears to develop de novo in some individuals following acute or chronic exposure to a wide variety of environmental agents including various pesticides, solvents, drugs, and air contaminants in so-called sick buildings. Some practitioners have attributed a broad spectrum of chronic medical conditions involving any and every organ system to chemical sensitivity ( Figure 1 ) (4) .
Efforts to formulate a case definition for chemical sensitivity, to identify relevant biomarkers, and to explore a variety of mechanisms for the condition have escalated over the past decade. Several conflicting schools of thought have evolved with respect to underlying mechanisms, ranging from the purely psychological to the wholly physiological. In the midst of the tumult surrounding chemical sensitivity lies a profound but little-recognized scientific debate concerning the origins of disease. Some participants in this debate are challenging currently accepted notions concerning the causes for many chronic illnesses. This paper attempts to clarify the nature of chemical sensitivity by describing a general mechanism that appears to underlie these cases; proposes a theory of disease based upon this general mechanism; and offers a set of testable postulates for corroborating or refuting this theory. Science is not about opinion or belief; it is about "guess and test," that is, formulating hypotheses and then devising experiments to test them.
Terminology
Phenomenologically, chemical sensitivity appears to develop in two stages (3, 4) . First is the loss of tolerance (possibly but not necessarily due to sensitization) following acute or chronic exposure to various environmental agents such as pesticides, solvents, or contaminated air in a sick building. Second is the subsequent triggering of symptoms by extremely small quantities of previously tolerated chemicals, drugs, foods, and food and drug combinations ( Figure 2) . Although sensitivity to chemicals may be one of the consequences of this two-stage process, the term chemical sensitivity does not appropriately describe the process involved.
There are two principal reasons for this. First, although chemical sensitivity certainly sounds like an inconvenient problem to have, the words fail to convey the potentially disabling nature of the condition and its postulated origins in a toxic exposure.
Some researchers balk at using the word toxic in this manner. However, numerous investigators from different geographic regions have published strikingly similar descriptions of individuals who report disabling illnesses after exposure to recognized environmental contaminants, albeit at levels not generally regarded as toxic (1, (9) (10) (11) (12) . Yet, for these individuals, the exposure appears to have been toxic.
Paracelsus aptly opined that dose makes the poison. However, as our knowledge has grown, it has become evident that dose + host makes the poison (for example, packyears of smoking plus a-l-antitrypsin deficiency). Similarly, in the case of chemical sensitivity, not everyone exposed in The following sections will discuss these clinical features, their incorporation in experimental designs, and how failure to do so might threaten research outcomes.
Stimulatory and Withdrawal Symptoms
Randolph first described the time course of the responses of these individuals to chemicals and foods (17) . He reported striking parallels between their symptoms and those associated with alcohol and drug addiction. Randolph viewed the food and caffeine addictions his patients exhibited as the bottom rungs in a hierarchy of addiction, proceeding from foods and food and drug combinations such as caffeine and alcohol on the lower rungs upward to nicotine and other naturally occurring and synthetically derived drugs (14) .
Chemically sensitive patients resemble drug addicts in that members of both groups often report intense cravings and debilitating withdrawal symptoms. However, chemically sensitive patients' responses are not primarily to drugs. These individuals more commonly report addictions to caffeine or certain foods. While drug addicts manifest ad-dicted behaviors (Latin ad "toward" + dicare "proclaim"), chemically sensitive patients respond as though they were ab-dicted (Latin ab "away from" + dicare "proclaim") and assiduously avoid the very substances addicted persons favor including alcohol, drugs and nicotine.
The stimulatory and withdrawal symptoms reported by chemically sensitive patients are frequently identical to those reported by normal persons exposed to much greater amounts of the same substances. For example, after drinking one cup of coffee, chemically sensitive patients may report feeling hyperactive, jittery, talkative, nervous, anxious, or experiencing paniclike symptoms (stimulatory phase). Hours to days later, they may report withdrawal symptoms such as fatigue, yawning, confusion, indecisiveness, irritability, depression, loss of motivation, blurred vision, headaches, flulike symptoms, hot or cold spells, or heaviness in their arms and legs (withdrawal phase). Similar symptoms occur during caffeine withdrawal among some low-to-moderate caffeine users in the general population (18) . Large numbers of chemically sensitive patients and many Gulf War veterans with unexplained illnesses report that one drink of an alcoholic beverage causes inebriation and/or a severe hangover (12, 15, 19) . These augmented responses suggest that those afflicted have lost their previous natural or native tolerance for such exposures.
Early in their illnesses, before eliminating caffeine from their diets, many chemically sensitive patients report having consumed chocolate, coffee, tea, or cola addictively, often in very large quantities (15) . Some drugs are often illustrated graphically using a biphasic curve or sine wave (Figure 3 ). (Figure 6 ), a phenomenon that occurs in alcohol, tobacco, and caffeine addictions. However, addiction to foods also is reported among chemically sensitive patients. Randolph described wheat, eggs, milk, and corn as the most common addictants in his patients (14, 17 
Testing the TILT Theory
After the germ theory of disease was introduced in the late 1800s, many overly enthusiastic investigators who were careless in their bacteriological techniques announced they had discovered causative agents for tuberculosis, yellow fever, and other diseases. These pronouncements and subsequent retractions became so frequent that in 1884 the President of the New York Academy of Medicine lamented that a bacteriomania had swept over the medical profession (25) . To prevent future such pseudodiscoveries, Robert Koch, who identified the organisms responsible for tuberculosis, anthrax, and cholera, proposed a set of rules for etiological verification. His postulates required that: the microbe must present in every case of the disease; it must be isolatable in pure culture; inoculating a healthy animal with the culture must reproduce the disease; and the microbe must be recoverable from the inoculated animal and be able to be grown again.
Just as bacteriomania engulfed the medical profession in the 1880s, chemomania is poised to engulf it now. Chemical sensitivity is in need of a set of postulates to ensure that future causal determinations are scientifically based. Below is a set of postulates that, if met, would confirm (and if not met, refute) that a person's symptoms were caused by a particular substance:
When a subject simultaneously avoids all chemical, food and drug incitants, remission ofsymptoms occurs (unmasking).
Enter EMU t t . 4 to 7 days -t-4 to 7 days *t Figure 7 . Graphic representation depicting the testing of the toxicant-induced loss of tolerance postulates using an environmental medical unit. In the left-hand portion of the figure, a chemically sensitive individual is experiencing symptoms in response to multiple exposures (chemicals, foods, drugs) before entering the environmental medical unit. Effects overlap in time. The effect of any particular exposure cannot be distinguished from the effects of other exposures, and the person's symptoms may appear to wax and wane unpredictably over time. Postulate 1-When all chemical, food,and drug incitants are avoided concurrently, remission of symptoms occurs. Anecdotally, patients report going through withdrawal or detox for the first several days during which they experience symptoms such as increased irritability, headaches, and depression. After 4 to 7 days, most report feeling well and theoretically are at a clean baseline. Postulate 2-A specific constellation of symptoms occurs with reintroduction of an incitant. Postulate 3-Symptoms resolve when the incitant is again avoided. Postulate 4-Reexposure to the same incitant within an appropriate window of time (estimated to be about 4-7 days) produces the same symptoms. For research purposes, challenges should be conducted in a double-blind, placebo-controlled manner.
* A specific constellation of symptoms occurs with reintroduction of a particular incitant. * Symptoms resolve when the incitant is again avoided. * With reexposure to the same incitant, the same constellation of symptoms reoccurs, provided that the challenge is conducted within an appropriate window of time. Clinical observations suggest that an ideal window is 4 to 7 days after the last exposure to the test incitant.
To apply these postulates (illustrated in Figure 7 ), the timing of exposures and the degree of masking should be rigorously controlled. To accomplish this, a hospitalbased clinical research facility, an EMU, is needed to isolate subjects from background exposures ( Figure 8 ) (4, 5, 15, 16, 26) . The EMU would be constructed, furnished, and operated to minimize exposure to airborne chemicals. For example, no disinfectants, perfumes, or pesticides would be allowed in the unit. Ventilation would maximize fresh outside air and provide optimal particulate and gas filtration. Patients would eat chemically less-contaminated foods and water, testing one food per meal to determine the effects of specific foods. If symptoms persisted despite this approach, fasting for a few days would be attempted before reintroducing single foods.
The rationale for housing subjects in an environmentally controlled facility for several days before challenges is 2- Figure 7 for etiological verification.
For research purposes, challenges must be performed in a double-blind, placebocontrolled manner. Patients with chronic fatigue syndrome, migraine headaches, seizures, depression, asthma, or unexplained illnesses such as Persian Gulf illness could also be tested for sensitivities in an EMU using these postulates. Thus, the EMU could be used to determine whether particular patients with these diagnoses had a masked form of this illness.
What evidence is there that unmasking patients in an EMU and conducting challenges within a 4-to 7-day window of time is either useful or necessary? Thousands of credible patients and dozens of physicians have attempted this approach. They report that patients' symptoms resolve within a few days after they enter such a facility and that robust symptoms occur when challenges are conducted after several days of avoidance. Other evidence corroborates these observations: Withdrawal symptoms of several days' to a week's duration are known to occur in some persons following cessation of exposure to nitroglycerine (dynamite workers' headaches) (27) , caffeine (18, 28) , nicotine, and alcohol. Note that these substances are chemically unrelated. In individuals chronically exposed to xylene (29) 
Conclusion
Good pathological and physiological theories provide "a unified, clear, and entirely intelligible meaning for a whole series of anatomical and clinical facts, and for the relevant experiences and discoveries of reliable observers..." (31) . Theories and experiments that overlook salient observations or do not control experimental conditions adequately may lead to erroneous conclusions. During the late 19th century, researchers collected sputum from patients with tuberculosis but were unsuccessful in culturing any organism. Some concluded that tuberculosis was not an infectious disease. These early investigators did not know that the tuberculin bacillus was fastidious and would grow out only after many weeks on a specialized culture medium. Correspondingly, scientists' abilities to observe and understand chemical sensitivity may depend on optimizing experimental conditions, that is, appropriate timing of challenges and use of an EMU for unmasking patients. To date, studies in this area have failed to unmask patients before challenge. When false positive and false negative responses occurred, investigators concluded that chemical sensitivity was psychogenic in origin (32, 33) .
In summary, features of TILT overlap those of allergy, addiction, and classical toxicity, yet TILT may be distinct from each of these. TILT appears to involve a two-step process (resembling allergic sensitization) in which persons lose specific tolerance (resembling addiction) for a wide range of common substances following a chemical exposure event (resembling toxicity). Just as the germ theory describes a class of diseases sharing the general mechanism of infection, the TILT theory of disease posits a class of chemically induced disorders characterized by loss of tolerance to chemicals, foods, drugs, and food and drug combinations. In the same way that fever is a symptom commonly associated with infectious diseases, chemical sensitivity may be a symptom associated with the TILT family of diseases. Although clinical case definitions have been developed that describe particular infectious diseases, no clinical case definition can be applied to the entire class of infectious diseases. The same may be true for TILT disorders. The fact that this phenomenon does not fit already accepted mechanisms for disease is often offered as evidence that the condition does not exist. However, the same criticism would have applied to the germ and immune theories of disease when they first were proposed. What is plausible depends on the biological knowledge of the time (34) .
Looking to the future, carefully conducted epidemiological studies and animal models likely will play important roles in characterizing the initiation stage of TILT during which tolerance is lost. In the meantime, rigorous testing of the second stage of TILT, that is, the triggering of symptoms by tiny doses of chemicals, foods, drugs, caffeine, or alcohol, is needed if progress in this area is to occur. Adopting a set of relevant testable hypotheses for etiological verification will ensure the credibility of those endeavors.
